Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-09-03

FDA Approved: FAMCICLOVIR — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' supplemental application for famciclovir, updating the labeling for this generic antiviral.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famciclovir (famciclovir)

Snippet

SUPPL AP for FAMCICLOVIR (FAMCICLOVIR)